Orthofix Medical Stock Price To Earnings To Growth

OFIX Stock

USD 18.68 0.19 1.01%

Orthofix Medical fundamentals help investors to digest information that contributes to Orthofix Medical's financial success or failures. It also enables traders to predict the movement of Orthofix Stock. The fundamental analysis module provides a way to measure Orthofix Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Orthofix Medical stock.

Short Long Term Debt Total Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Orthofix Medical Company Price To Earnings To Growth Analysis

Orthofix Medical's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.

PEG Ratio

PE Ratio

EPS Growth

More About Price To Earnings To Growth | All Equity Analysis

Current Orthofix Medical Price To Earnings To Growth

0.33 X

Most of Orthofix Medical's fundamental indicators, such as Price To Earnings To Growth, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Orthofix Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Orthofix Price To Earnings To Growth Driver Correlations

Understanding the fundamental principles of building solid financial models for Orthofix Medical is extremely important. It helps to project a fair market value of Orthofix Stock properly, considering its historical fundamentals such as Price To Earnings To Growth. Since Orthofix Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Orthofix Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Orthofix Medical's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Long Term Debt	Good Will	Property Plant Equipment	Current Deferred Revenue	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.95	0.66	-0.58	0.92	0.62	0.75	0.69	0.45	0.84	0.68	0.55	0.75	0.55	-0.19	0.32	-0.26	0.56	-0.21	-0.49	0.69	0.66	0.69
Total Stockholder Equity	0.95		0.44	-0.58	0.94	0.49	0.55	0.63	0.17	0.81	0.71	0.34	0.57	0.59	-0.28	0.58	-0.51	0.63	-0.34	-0.53	0.7	0.65	0.69
Net Debt	0.66	0.44		-0.43	0.54	0.65	0.74	0.46	0.81	0.47	0.37	0.61	0.82	0.02	-0.09	-0.32	0.49	0.15	0.36	0.0	0.43	0.55	0.49
Retained Earnings	-0.58	-0.58	-0.43		-0.81	0.11	-0.27	0.0	-0.15	-0.81	-0.6	-0.21	-0.44	-0.02	0.8	-0.06	0.09	-0.65	0.34	0.53	-0.79	-0.78	-0.81
Accounts Payable	0.92	0.94	0.54	-0.81		0.35	0.52	0.46	0.24	0.9	0.73	0.38	0.61	0.42	-0.54	0.4	-0.34	0.71	-0.32	-0.58	0.8	0.77	0.81
Net Receivables	0.62	0.49	0.65	0.11	0.35		0.8	0.88	0.66	0.27	0.41	0.66	0.75	0.52	0.3	0.06	0.13	0.21	0.39	-0.05	0.25	0.27	0.26
Total Liab	0.75	0.55	0.74	-0.27	0.52	0.8		0.81	0.8	0.56	0.61	0.79	0.94	0.54	0.14	-0.16	0.19	0.38	0.06	-0.26	0.54	0.52	0.53
Total Current Assets	0.69	0.63	0.46	0.0	0.46	0.88	0.81		0.47	0.36	0.65	0.56	0.74	0.77	0.24	0.33	-0.2	0.42	-0.01	-0.17	0.45	0.42	0.44
Short Term Debt	0.45	0.17	0.81	-0.15	0.24	0.66	0.8	0.47		0.31	0.16	0.83	0.77	0.09	0.09	-0.59	0.64	0.08	0.4	-0.03	0.17	0.19	0.19
Intangible Assets	0.84	0.81	0.47	-0.81	0.9	0.27	0.56	0.36	0.31		0.65	0.52	0.63	0.36	-0.53	0.15	-0.21	0.75	-0.33	-0.81	0.79	0.66	0.75
Common Stock	0.68	0.71	0.37	-0.6	0.73	0.41	0.61	0.65	0.16	0.65		0.27	0.72	0.57	-0.36	0.4	-0.32	0.78	-0.28	-0.42	0.94	0.89	0.94
Long Term Debt	0.55	0.34	0.61	-0.21	0.38	0.66	0.79	0.56	0.83	0.52	0.27		0.71	0.46	-0.04	-0.36	0.32	0.42	0.17	-0.43	0.26	0.19	0.24
Good Will	0.75	0.57	0.82	-0.44	0.61	0.75	0.94	0.74	0.77	0.63	0.72	0.71		0.38	-0.07	-0.16	0.27	0.48	0.17	-0.28	0.7	0.69	0.71
Property Plant Equipment	0.55	0.59	0.02	-0.02	0.42	0.52	0.54	0.77	0.09	0.36	0.57	0.46	0.38		0.13	0.53	-0.59	0.57	-0.41	-0.43	0.36	0.26	0.32
Current Deferred Revenue	-0.19	-0.28	-0.09	0.8	-0.54	0.3	0.14	0.24	0.09	-0.53	-0.36	-0.04	-0.07	0.13		-0.1	0.1	-0.67	0.2	0.52	-0.53	-0.47	-0.55
Net Tangible Assets	0.32	0.58	-0.32	-0.06	0.4	0.06	-0.16	0.33	-0.59	0.15	0.4	-0.36	-0.16	0.53	-0.1		-0.91	0.35	-0.45	-0.16	0.26	0.24	0.26
Long Term Debt Total	-0.26	-0.51	0.49	0.09	-0.34	0.13	0.19	-0.2	0.64	-0.21	-0.32	0.32	0.27	-0.59	0.1	-0.91		-0.37	0.72	0.36	-0.2	-0.11	-0.17
Capital Surpluse	0.56	0.63	0.15	-0.65	0.71	0.21	0.38	0.42	0.08	0.75	0.78	0.42	0.48	0.57	-0.67	0.35	-0.37		-0.36	-0.78	0.79	0.63	0.75
Deferred Long Term Liab	-0.21	-0.34	0.36	0.34	-0.32	0.39	0.06	-0.01	0.4	-0.33	-0.28	0.17	0.17	-0.41	0.2	-0.45	0.72	-0.36		0.43	-0.26	-0.15	-0.22
Long Term Investments	-0.49	-0.53	0.0	0.53	-0.58	-0.05	-0.26	-0.17	-0.03	-0.81	-0.42	-0.43	-0.28	-0.43	0.52	-0.16	0.36	-0.78	0.43		-0.53	-0.27	-0.43
Net Invested Capital	0.69	0.7	0.43	-0.79	0.8	0.25	0.54	0.45	0.17	0.79	0.94	0.26	0.7	0.36	-0.53	0.26	-0.2	0.79	-0.26	-0.53		0.94	0.99
Net Working Capital	0.66	0.65	0.55	-0.78	0.77	0.27	0.52	0.42	0.19	0.66	0.89	0.19	0.69	0.26	-0.47	0.24	-0.11	0.63	-0.15	-0.27	0.94		0.97
Capital Stock	0.69	0.69	0.49	-0.81	0.81	0.26	0.53	0.44	0.19	0.75	0.94	0.24	0.71	0.32	-0.55	0.26	-0.17	0.75	-0.22	-0.43	0.99	0.97

Click cells to compare fundamentals

Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.

Competition

Predict Orthofix Medical

Orthofix Price Earnings To Growth Ratio

Price Earnings To Growth Ratio

(0.009696)

At this time, Orthofix Medical's Price Earnings To Growth Ratio is fairly stable compared to the past year.

Based on the latest financial disclosure, Orthofix Medical has a Price To Earnings To Growth of 0.3269 times. This is 53.96% lower than that of the Health Care Equipment & Supplies sector and 82.79% lower than that of the Health Care industry. The price to earnings to growth for all United States stocks is 93.31% higher than that of the company.

Orthofix Price To Earnings To Growth Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Orthofix Medical's direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Orthofix Medical could also be used in its relative valuation, which is a method of valuing Orthofix Medical by comparing valuation metrics of similar companies.

Orthofix Medical is currently under evaluation in price to earnings to growth category among its peers.

Orthofix Medical Current Valuation Drivers

We derive many important indicators used in calculating different scores of Orthofix Medical from analyzing Orthofix Medical's financial statements. These drivers represent accounts that assess Orthofix Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Orthofix Medical's important valuation drivers and their relationship over time.

	2019	2020	2021	2022	2023	2024 (projected)
Market Cap	873.0M	828.1M	612.2M	411.7M	495.1M	426.2M
Enterprise Value	824.2M	756.8M	546.8M	380.9M	591.6M	441.2M

Orthofix Medical ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Orthofix Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Orthofix Medical's managers, analysts, and investors.

Environmental

Governance

Social

Orthofix Fundamentals

	Return On Equity	-0.21
	Return On Asset	-0.0237
	Profit Margin	(0.15) %
	Operating Margin	(0.09) %
	Current Valuation	828.28 M
	Shares Outstanding	38.21 M
	Shares Owned By Insiders	4.99 %
	Shares Owned By Institutions	92.30 %
	Number Of Shares Shorted	2.51 M
	Price To Earning	338.00 X
	Price To Book	1.37 X
	Price To Sales	0.91 X
	Revenue	746.64 M
	Gross Profit	337.17 M
	EBITDA	(86.98 M)
	Net Income	(151.4 M)
	Cash And Equivalents	59.54 M
	Cash Per Share	2.98 X
	Total Debt	134.2 M
	Debt To Equity	0.08 %
	Current Ratio	3.15 X
	Book Value Per Share	13.76 X
	Cash Flow From Operations	(45.75 M)
	Short Ratio	12.36 X
	Earnings Per Share	(3.14) X
	Price To Earnings To Growth	0.33 X
	Target Price	24.4
	Number Of Employees	1.63 K
	Beta	1.05
	Market Capitalization	713.84 M
	Total Asset	925.32 M
	Retained Earnings	(150.14 M)
	Working Capital	255.22 M
	Current Asset	147.87 M
	Current Liabilities	52.94 M
	Net Asset	925.32 M

About Orthofix Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Orthofix Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Orthofix Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Orthofix Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Orthofix Stock Analysis

When running Orthofix Medical's price analysis, check to measure Orthofix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthofix Medical is operating at the current time. Most of Orthofix Medical's value examination focuses on studying past and present price action to predict the probability of Orthofix Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthofix Medical's price. Additionally, you may evaluate how the addition of Orthofix Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC